P38B MAPK INTERACTS WITH SET REGULATING ITS INHIBITORY EFFECT ON PP2A ACTIVITY IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Arriazu, E. [1 ]
Vicente, C. [1 ]
Pippa, R. [1 ]
Marcotegui, N. [1 ]
Igea, A. [2 ]
Leon, E. [1 ]
Chocarro, S. [1 ]
Soto, M. [1 ]
Nebreda, A. R. [2 ]
Odero, M. D. [1 ,3 ,4 ]
机构：
[1] Univ Navarra, Oncohematol, Ctr Applyed Med Res, Pamplona, Spain
[2] Inst Res Biomed, Barcelona, Spain
[3] Inst Invest Sanitaria Navarra IdiSNA, Navarra, Spain
[4] Univ Navarra, Dept Biochem & Genet, Pamplona, Spain
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P536
引用
收藏
页码：205 / 205
页数：1
相关论文
共 33 条
  • [1] Effect of FTY720 on the SET–PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity
    R Pippa
    A Dominguez
    D J Christensen
    I Moreno-Miralles
    M J Blanco-Prieto
    M P Vitek
    M D Odero
    Leukemia, 2014, 28 : 1915 - 1918
  • [2] p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells
    Gianni, M.
    Peviani, M.
    Bruck, N.
    Rambaldi, A.
    Borleri, G.
    Terao, M.
    Kurosaki, M.
    Paroni, G.
    Rochette-Egly, C.
    Garattini, E.
    LEUKEMIA, 2012, 26 (08) : 1850 - 1861
  • [3] p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells
    M Gianni
    M Peviani
    N Bruck
    A Rambaldi
    G Borleri
    M Terao
    M Kurosaki
    G Paroni
    C Rochette-Egly
    E Garattini
    Leukemia, 2012, 26 : 1850 - 1861
  • [4] p38α MAPK interacts with and inhibits RARα: Suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells
    Garattini, Enrico
    Gianni, Maurizio
    Terao, Mineko
    Kurosaki, Mami
    Paroni, Gabriela
    Loparco, Maria Immacolata
    Peviani, Marco
    CANCER RESEARCH, 2012, 72
  • [5] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
    I Cristóbal
    L Garcia-Orti
    C Cirauqui
    M M Alonso
    M J Calasanz
    M D Odero
    Leukemia, 2011, 25 : 606 - 614
  • [6] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
    Cristobal, I.
    Garcia-Orti, L.
    Cirauqui, C.
    Alonso, M. M.
    Calasanz, M. J.
    Odero, M. D.
    LEUKEMIA, 2011, 25 (04) : 606 - 614
  • [7] The PP2A Subunit B55α Suppresses Survival Signaling in Acute Myeloid Leukemia Cells
    Ruvolo, Peter P.
    Ruvolo, Vivian
    Zeng, Zhihong
    Qui, YiHua
    Zhou, Liran
    Gallagher, Kelly E.
    Konopleva, Marina
    Kornblau, Steven M.
    Andreeff, Michael
    BLOOD, 2011, 118 (21) : 182 - 182
  • [8] PP2A IMPAIRED ACTIVITY IS A COMMON EVENT IN ACUTE MYELOID LEUKEMIA, AND ACTIVATION BY FORSKOLIN TREATMENT INDUCES A POTENT ANTILEUKEMIC EFFECT
    Cristobal, I.
    Garcia-Orti, L.
    Urquiza, L.
    Alonso, M.
    Bandres, E.
    Calasanz, M. J.
    Odero, M. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 460 - 460
  • [9] Constitutive activation of p38 MAPK, but not NF-κB, in leukemia cells from patients with acute myeloid leukemia
    Liu, RY
    Fan, C
    Liu, GQ
    Zuckerman, KS
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 113 - 114
  • [10] Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity
    Pippa, R.
    Dominguez, A.
    Christensen, D. J.
    Moreno-Miralles, I.
    Blanco-Prieto, M. J.
    Vitek, M. P.
    Odero, M. D.
    LEUKEMIA, 2014, 28 (09) : 1915 - 1918
1234